Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.1 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.1 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.1 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.2.5.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.2.5.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.2.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.2.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.600EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.600EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.600ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.600ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.600EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.600EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.600ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.600ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.12 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.12 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12 (Gamma)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.1.12 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.1.12 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.12 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.12 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.12 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.45EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.5.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.5.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.5.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used